威海百合生物技术股份有限公司关于职工代表大会选举职工代表董事的公告

Core Points - The company held its first extraordinary general meeting on September 26, 2025, where it approved the proposal to cancel the supervisory board and amend the company’s articles of association, including the addition of employee representative directors [1][4] - Yao Jianwei was elected as the employee representative director during the employee representative assembly held on the same day, with his term lasting until the end of the fourth board's term [1][2] Meeting Details - The extraordinary general meeting took place at the company's R&D building in Rongcheng, Shandong Province, with all nine current directors and three supervisors in attendance [5][6] - The meeting utilized a combination of on-site and online voting, complying with relevant laws and regulations [6] - Two main proposals were passed: the cancellation of the supervisory board and the amendment of internal governance systems, with the first requiring a two-thirds majority and the second a simple majority [6] Legal Compliance - The meeting was witnessed by a law firm, which confirmed that the procedures followed were in accordance with legal and regulatory requirements [6]